Coronavirus Update
learn more

James Shannon

Joined May 2015 (also served February 2010–April 2012) Current Role Compensation Committee member Current Experience Director: Horizon Therapeutics plc Director: Kyowa Kirin (NA) Director: Immodulon Therapeutics Limited Director: ProQR Therapeutics NV Director: MyTommorows Past Experience Chief Medical Officer: GlaxoSmithKline Global Head of Pharma Development: Novartis AG Director: Biotie Director: Circassia Director: Crucell Director: Endocyte Director, Interim Chief Executive Officer: Cerimon Pharmaceuticals Education Queen’s University of Belfast: undergraduate and postgraduate degrees in medicine and cardiology